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Abstract
Objective: To determine the difference adiponectin serum 
levels in pregnant patient with severe preeclampsia and 
normotency in Manado.
Methods: This study is a cross sectional study which the 
number of samples obtained was 52 samples in which the 
sample was divided into 26 pregnant samples with severe 
preeclampsia and 26 control samples. Samples were taken 
from Prof. dr. R. D. Kandou Manado Hospital and network 
hospitals around Manado within the inclusion and exclusion 
criteria. All patients were explained about the research 
procedure and singning the informed consent and take a 
blood sample by using the ELIZA method. After the data is 
collected, it is entered into the SPSS version 23.0 program 
for data analysis.
Result: There was a signifi cant relationship between 
adiponection serum levels with the incidency of severe 
preeclampsia and normotency. But for body mass index 
variables there were no signifi cant differences by using T 
test (independent sample) in each severe preeclampsia and 
normotency pregnancy group where p=0.903. Body mass 
index, height, weight, and weight gain during pregnancy 
showed that there is no difference between cases and 
controls (p>0.05) which means that body mass index is 
not related to the stete of the severe preeclampsia and 
normotency.
Conclusions: There was no relationship between BMI, 
age, parity, smoking, baby outcomes, delivery method and 
gestational age with the incidence of severe preeclampsia 
and normotency against adiponectin in this study. 
Keywords: adiponectin, obstetrics, preeclampsia.
Abstrak
Tujuan: Untuk mengetahui perbedaan kadar adiponektin 
serum pada pasien hamil preeklamsia berat dengan hamil 
normal di Kota Manado. 
Metode: Studi ini merupakan studi potong lintang.  Jumlah 
Sampel yang didapatkan sebesar 52 sampel dimana sampel 
dibagi menjadi 26 sampel hamil dengan preeklamsia berat 
dan 26 sampel kontrol. Sampel diambil dari RSUP Prof. 
dr. R. D. Kandou Manado dan rumah sakit jejaring sekitar 
manado yang memenuhi kriteria inklusi dan eksklusi. 
Semua pasien dijelaskan mengenai prosedur penelitian 
dan penandatanganan inform consent baru dilakukan 
pengambilan sampel darah untuk dilakukan pemeriksaan 
laboratorium dengan menggunakan metode ELISA. Setelah 
data dikumpulkan, maka dimasukkan ke dalam program 
SPSS versi 23.0 untuk data analisis.
Hasil: Perhitungan dengan menggunakan uji statistik 
Mann - Whitney menunjukkan bahwa terdapat perbedaan 
bermakna nilai rata-rata kadar adiponektin pada pasien hamil 
normal dengan pasien PEB (p = 0,000). Adanya hubungan 
bermakna kadar adiponektin dengan kejadian preeklamsia 
berat. Namun untuk variabel IMT yang dilakukan secara uji t 
(sampel independen) didapatkan kesimpulan tidak terdapat 
perbedaan bermakna pada masing-masing kelompok 
normotensi dan kelompok preeklamsia berat di mana p= 
0,903, indeks massa tubuh, tinggi badan, berat badan, serta 
pertambahan berat badan selama kehamilan tidak berbeda 
antara kasus dan kontrol (p>0,5). Ini berarti bahwa IMT tidak 
berhubungan dengan keadaan terjadinya preeklamsia berat.
Kesimpulan: Tidak didapatkan hubungan antara IMT, 
usia, paritas, merokok, luaran bayi, cara persalinan dan 
usia kehamilan dengan kejadian preeklamsia berat dan 
normotensi  terhadap adiponektin pada penelitian ini.
Kata kunci: adiponektin,  obstetri, preeklamsia.
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Preeclampsia is a specifi c condition in 
pregnancy characterized by placental dysfunction 
and maternal response to systemic infl ammation 
with endothelial activation and coagulation. 
Preeclampsia is a clinical syndrome where 
there is a decrease in organ perfusion due to 
vasospasm and endothelial activity characterized 
by hypertension, edema, and proteinuria that 
arise at gestational age above 20 weeks or 
immediately after delivery.1,2 However, some 
other women show hypertension accompanied 
by other multisystem disorders that indicate a 
severe condition of preeclampsia even though the 
patient does not have a proteinuria. 3,4 Frequency 
of preeclampsia for each country varies due to 
many factors. In Indonesia is around 3-10% while 
in developing countries like the United Stated, it 
is reported that the incidence of preeclampsia is 
about 5% of all pregnancies. The World Health 
Organization (WHO) states that hypertension 
in pregnancy is a major cause of maternal and 
fetal mortality and morbidity. 3,5 About 50.000-
70.000 deaths are reported due to preeclampsia. 
This disease occurs in 3-5% of pregnant women 
and is a major cause of death of pregnant 
women. The impact on pregnant women varies 
from severe hypertension, crisis hypertension, 
urgency, superimposed preeclampsia, HELLP 
syndrome, to eclampsia. Maternal Health shows 
that the incidence rate was 24.7% in 2011, 26.9% 
in 2012, and 27.1% in 2013 that effect for fetus 
such as premature birth, stunted fetal growth to 
fetal death. 2,6
Treatment of severe preeclampsia is closely 
related to the use of antihypertensi. Calcium 
Channel Blocker acts on arteriolar smooth muscle 
and cause vasodilatation by inhibiting the entry 
of calcium into cell. Nifedipin is one of these 
classes of drugs that have been used since the 
last decade. The recommended dose is 10 mg 
orally can be repeated every 15-30 minutes, with 
a maximum dose of 30mg. Beside nifedipine, the 
drug used is also nicardipine which is a parenteral 
calcium that works reduce blood pressure in 20 
minutes with 4-6 hours duration. Nicardipine 
more selectively in myocardial blood vessels, with 
lower side effect of tachycardia.  Futhermore, 
Magnesium Sulfat prevent seizure in severe 
preeclampsia. The RCOG guidelines recommend 
loading magnesium sulphate 4gram for 5-10 
minutes followed by a maintenance dose of 1-2 
gram/hours for 24 hours postpartum or after 
the last seizure but monitoring of urine output, 
refl ex of patella, frequency of breath and oxygen 
saturation.7,8
Severe Preeclampsia that is not resolved will 
have an impact on mother and baby. In the 
mother can occur brain haemorrhage which 
is the impact of cerebrovascular, neurological 
disorders, kidney and liver function, pulmonary 
edema, and blot clotting. While the fetus or baby 
can fetal growth restriction, preterm labor that 
can acute respiratory distress until death.2,3,9
Adiponectin is an important adipocytokine 
secreted mainly by fats that contain adipocytes 
and plays important role in glucose and lipid 
metabolism, infl ammation and oxidative stress. 
Changes in adiponectin levels have been shown 
to directly affect lipid and glucose metabolism 
which further increase lipid synthesis, free faty 
acids, insulin resistance, obesity, cardiovascular 
disease, type 2 diabetes and infl ammatory 
cytokines. It is a complex and actibe endocrine 
organ that plays an important role in regulating 
lipid and glucose. Adiponectin accounts for about 
0.01% of all plasma protein (5-10ᶬg/ml).4,5
Adiponectin as an adipose tissue secretes 
various proteins into the circulation. These 
proteins are collectively called adipocytokines 
which are commonly referred to as adipokines. 
This adipokin consist of adiponectin, free faty 
acid (FFA), leptin, TNF-a, Plasminogen Activator 
Inhibitor-resistin, bone morphogenic protein, 
Insulin like growth factor, interleukin-I.5,6 Adipose 
tissue is not only a place to store fat, but also 
an endoctine organ that plays an important 
role in the interaction of endocrine, metabolic, 
and infl ammatory signals to regulate the body 
homeostatic energy. Increase adipose tissue 
will also be an increase in proinfl ammatory 
adipokines secretion along with a decrease in 
protective adiponectin secretion.
Pathophysiological of preeclampsia 
concepts related to atherosclerosis, 
endothelial dysfunction, insulin resistance, and 
infl ammation. Many adipocyte hormones such 
as tumor necrosis factor, leptin, adiponectin, and 
interleukin 6 collectively called adiponectin that 
play an important role in the infl ammatory and 
atherosclerotic processes. It is one of the many 
specifi c fatty tissue proteins and expressed and 
secreted from fat tissue.4-6 In preeclampsia there 
is an immunological defi ciency of trophoblast 
invasion into the spiral arteries which cause 
placental hypoperfusion and changes trigger 
activation of the vascular endothelium.
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Experimental and clinical studies have stated 
that low plasma adiponectin levels are associated 
with metabolic factors associated with obesity 
and vascular disease both of which are risk factors 
for preeclampsia.
METHODS
This study is a cross sectional study to assess 
the comparison of adiponectin serum level in 
severe preeclampsia and normotency patients in 
Obstetrics and Gynecology.
The study was conducted at Prof. dr. R.D. 
Kandou Hospital Manado, Pancaran Kasih 
Hospital and Bhayangkara Hospital from Juli 
2019 to December 2019.
The population in this study were all 
women who had clinical symptoms of severe 
preeclampsia at Prof. dr. R. D. Kandou Hospital 
and networking hospital in Manado. Samples 
were selected by history, physical examination 
and supporting examinations. Samples that met 
the inclusion criteria and had signed the consent 
form were included in the study. The sample used 
by consecutive sampling.
The inclusion criteria was patients with aterm 
pregnancy which have a high blood pressure and 
normotency and the ultrasonography study show 
intrauterine pregnancy in the fi elds of Obstetrics 
and Gynecology and willing to participate in 
research. The exclusion criteria was have a history 
of diabetes mellitus, cardiac or lung disease, 
malnutrition, HIV infection, refuse to participate 
in research, in medicine using antimicrobials, 
in treatment using immunosuppressants, fetal 
death, or preterm pregnancy. 
The independent variable is severe 
preeclampsia and normotency patient and the 
dependent variable is adiponectin serum and 
body mass index.
Sampling was carried out at patient that 
met the inclusion criteria. Samples measured 
weight, height. After that the sample is taken 
blood sample from the vein about 5cc and has 
received an explanation and has signed a written 
statement of consent following the research that 
has been provided.
Sampling was carried out on blood sampling in 
patients and was sent to laboratory examination 
by using the ELIZA method. After the data is 
collected it is entered into the SPSS version 23.0 
program for data anaylisis.
RESULTS
This research was conducted at Prof. dr. R.D. 
Kandou Hospital and networking hospital in 
Manado. The number of samples studied were 
52 women who had clinical symptoms of severe 
preeclampsia and normotency in the fi eld of 
Obstetrics and Gynecology who met the inclusion 
criteria. 
Table 1 illustrates the distribution of research 
subjects based on age, gravidity, gestasional age, 
education, BMI, mode of delivery, the history of 
smoke, occupation.
The highest age distribution in the case of 
severe preeclampsia and normotency was in the 
reproductive age group of  up to 20 years and 
below 35 years, 14 people and 15 people (53.8%, 
%7.6% p = 0,382). The results of the distribution 
of parity where multigravida were more dominant 
in the severe preeclampsia and normotency were 
20 people and 18 people (77%, 69% p = 0.455). 
The results of the distribution of gestational 
age presentation in the severe preeclampsia 
group mostly >37 weeks-<40 weeks namely 
16 people (61.5%) and for  normotency patient 
were 20 people (77%)( p=0.542). The result of 
the distribution education levels group in severe 
preeclampsia mostly in primary and junior high 
school education which 13 people (50%) and 
normotency woman were 15 people (67%) (p= 
0.324). Moreover, body mass index in the severe 
preeclampsia group mostly from the overweight 
and obesity groups of 19 people (75.1%) and 
normotency of 18 people (69.2%)(p = 0.451). 
The distribution result in group of severe 
preeclampsia and normotency that show the 
infant output is about >2500 gram-< 4000gram 
were 25 people (96.2%) and 24 patient (82,5%) 
(p-0.358). Futher more, the results of distribution 
mother delivery in normotency mostly by vaginal 
delivery 17 people (65.4%) neither in severe 
pregnancy by caesarean delivery with 21 people 
(80%) (p= 0.435)  In the severe preeclampsia, 17 
people (54.4%, p = 0.358) were smoke.
Table 2 illustrates the adiponectin serum in 
normotency and severe preeclampsia.  In patient 
with normotency, adiponectin serum levels mean 
and standard deviation showed 4.423±1.08 
while in severe preeclampsia adiponectin serum 
level meand and standard deviation showed 
2.628±0.477. The calculation method using 
the Mann-Whitney statistical test showed that 
there were signifi cant differences in the average 
value of adiponectin serum level in severe 
preeclampsia (p=0.000). There was a signifi cant 
relationship between adiponection serum levels 
with the incidency of severe preeclampsia and 
normotency.
Table 3 illustrates the distribution of body 
mass index variable and adiponectin serum in 
normotency and severe preeclampsia. grouping 
types of microorganisms. But for body mass index 
variables there were no signifi cant differences by 
using T test (independent sample) in each severe 
preeclampsia and normotency pregnancy group 
where p=0.903. Body mass index, height, weight, 
and weight gain during pregnancy showed that 
there is no difference between cases and controls 
(p>0.05) which means that body mass index is not 
related to the state of the severe preeclampsia 
and normotency.
Table 1. Characteristics of Research subjects
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DISCUSSION
In this study, 52 patients were eligible. All 
subjects of this study have met the inclusion 
criteria and exclusion criteria and have signed a 
form of willingness to be involved in this study. 
In this study, sample characteristics were 
assessed from maternal age, education, 
occupation, and body mass index. In table 1, we 
can see a comparison of the characteristics of 
a sample of pregnancy with normotension and 
severe preeclampsia. The distribution of research 
subjects according to the age of group of mothers 
in the study was <20->35 years. The sample 
distribution in this study based on the age of the 
mother with the higher percentage in the age 
group of 20-35 years both in the normotension 
group of 15 people (57.6%) and the preeclampsia 
group of 14 people (53.8%). According to the 
theory that preeclampsia is more often found 
in the early and late reproductive age, namely 
in adolescents or over the age of >35 years, 
but in this study does not fi t the theory of the 
causes of preeclampsia which cause a decrease 
in adiponectin levels. It is not in accordance with 
the theory of the factors causing the occurrence 
of preeclampsia in Prof. dr. R. D. Kandou Hospital 
and its surroundings based on the age group of 
20-35 years.
The highest percentage of parity was 
multigravida in both normotension and severe 
preeclampsia groups, this is different from the 
theory that the frequency of preeclampsia is 
higher in primigravida compared to multigravida 
because the formation of antibody inhibitors 
(blocking antibodies) is not perfect against 
placental antigens so that arising from an 
immune response that does not benefi t placental 
histocompability and increase the risk of 
preeclampsia. 10
In this study an analysis show the relationship 
between serum levels of adiponectin in 
normotency and preeclampsia, in which there is 
a signifi cant difference in the level of adiponectin 
with the average value of adiponectin levels 
obtained in the normotension group is 39.46 
while in the preeclampsia group is 13.54 (p=0.00). 
This shows the relationship between adiponectin 
levels and the incidence of preeclampsia. An 
increased risk of preeclampsia has been noted 
to be related to several conditions related to 
insulin resistance, including gestational diabetes, 
maternal obesity, and excessive weight gain 
during pregnancy.2
The pathophysiology linking maternal 
obesity with pregnancy induced preeclampsia 
is an intensive subject of research with insulin 
resistance which plays an important role.2,6 
Although insulin resistance is increased in normal 
pregnancy activities to facilitate glucose transfer 
to the fetus and support the rapid growth of the 
fetus and placenta.
Research reports indicate that insulin 
signals and angiogenesis are closely related 
and irregularities in angiogenesis and insulin 
resistance can cause change in cellular critical 
function, endothelial cell injury, and consequently 
an increased risk for preeclampsia.
In this study table 3 shows that there is no 
relationship between the value of body mass 
index with the incidence of preeclampsia and 
the average body mass index in normotensive 
pregnancy is 27.84 and there is a decrease 
in the average body mass index value in the 
preeclampsia group 27.69 with a p-value 0.903. 
At the Hutzel-Wayne University Hospital in 
22 normotensive pregnant women and 77 
preeclampsia women showed that there was 
decrease in adiponectin levels with increasing 
maternal body mass index. Adiponectin levels in 
Table 3. Variable Distribution of Body Mass Index and Adiponectin Serum in Normotency and Severe Preeclampsia
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the weight preeclampsia group with overweight 
and obesity (BMI>25kg/m2) were lower than 
the weight preeclampsia group with normal 
weight. Women with preeclampsia also had a 
higher BMI compared to normotensive control. 
This is because in obese there is an increase in 
infl ammatory mediating factors such as IL6, C 
reactive peptide, TNF-alpha, and macrophages 
from the placenta which can cause dysfunction 
in the endothelial and vascular. But in this study, 
the adiponectin correlation test with BMI showed 
a weak correlation 5,6
CONCLUSION
From the results of this study it was found that 
adiponectin levels in severe preeclampsia were 
signifi cantly lower compared to normotensive 
pregnancy so it can be concluded that adiponectin 
levels were associated with the incidence of 
severe preeclampsia.
SUGGESTION
Further research to assess the relationship of 
adiponectin, preeclampsia, body mass index using 
a large sample and not only for aterm pregnancy 
but continue by examining the adiponectin levels 
in fi rst/second trimester pregnant women as 
predictor of preeclampsia. Serum adiponectin 
examination can be considered as a marker for 
preeclampsia.
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